{
  "actions": [
    {
      "acted_at": "2016-04-18", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-04-18", 
      "action_code": "H11100-A", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2016-04-18", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2016-04-18", 
      "action_code": "H11100", 
      "committees": [
        "HSII"
      ], 
      "references": [], 
      "text": "Referred to House Natural Resources", 
      "type": "referral"
    }, 
    {
      "acted_at": "2016-04-22", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2016-04-27", 
      "action_code": "", 
      "committees": [
        "HSII"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4983-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Natural Resources", 
      "committee_id": "HSII"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Natural Resources", 
      "committee_id": "HSII", 
      "subcommittee": "Subcommittee on Indian, Insular and Alaska Native Affairs", 
      "subcommittee_id": "24"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-04-18", 
  "number": "4983", 
  "official_title": "To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr5189-114", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "G000568", 
    "district": "9", 
    "name": "Griffith, H. Morgan", 
    "state": "VA", 
    "thomas_id": "02070", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-04-18", 
  "subjects": [
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Health", 
    "Health information and medical records", 
    "Health promotion and preventive care", 
    "Indian social and development programs", 
    "Minority health", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2016-04-18T04:00:00Z", 
    "text": "This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)"
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:28:59Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr4983.xml"
}